PACTR202210522771809招募中未知
Association of Vascular Endothelial Growth Factor (VEGF) serum levels And Ankylosing Spondylitis in Egyptian patients
Hossam salaheldin Abdelmohsen Labib0 个研究点目标入组 70 人开始时间: 2022年10月21日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 70
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 19 Year(s) 至 44 Year(s)（—）
- 性别
- All
入选标准
- •Adult AS(ankylosing spondylitis ) patients
- •20-60 years old
- •met the modified New York criteria for AS.
排除标准
- •Patients with any associated rheumatic diseases.
- •- patients with cancers.
- •- Diabetic patients
研究者
相似试验
招募中
不适用
Vascular Endothelial Growth Factor, thrombelastography and coagulation in the context of etiology, outcome and clinical course of patients after circulatory arrestI46Cardiac arrestDRKS00033234BG-Klinikum Unfallkrankenhaus Berlin150
已完成
不适用
The effect of vascular endothelial growth factor taking tube shunt for neovascular glaucomaneovascular glaucomaJPRN-UMIN000018407Yokohama City university center hospital the department of opthalmology20
招募中
3 期
A clinical trial to study the levels of vascular endothelial growth factor in the fluid in the front part of the eye in cases of occlusion of venous supply of the eye and to correlate with the clinical features and nerve thickness as obtained by scanning and nerve function testsCTRI/2012/12/003270arayana Nethralaya30
已完成
不适用
Effect of anti-vascular endothelial growth factor (VEGF) drugs in chronic central serous chorioretinopathy (CSC)chronic central serous chorioretinopathyJPRN-UMIN000014110Kansai medical university takii hospital10
已完成
不适用
Anti-vascular endothelial growth factor therapy for ocular diseases of neovascularizatioretinopathy of prematurity neovascular glaucome vasoproliferative tumor choroidal neovascularizationJPRN-UMIN000027243School of Medicine Toho University20